Li Jin, Zhang Yi, Fu Xinxing, Bi Jingtao, Li Yanhong, Liu Bo, Zhang Luo
a Department of Otolaryngology Head and Neck Surgery , Beijing TongRen Hospital, Capital Medical University , Beijing , China.
b Beijing Institute of Otolaryngology , Key Laboratory of Otolaryngology Head and Neck Surgery (Capital Medical University), Ministry of Education , Beijing , China.
Acta Otolaryngol. 2018 Jun;138(6):542-547. doi: 10.1080/00016489.2017.1422084. Epub 2018 Jan 18.
The association between type 2 diabetes mellitus (T2DM) and hearing loss has not been fully investigated and there is little information on the effects of pre-diabetes on alterations in auditory function in Chinese subjects.
The study recruited 51 patients with T2DM, 55 patients with pre-diabetes and 43 control subjects. Auditory function was assessed by pure tone audiometry (PTA) tests and distortion product of otoacoustic emissions (DPOAEs). Tinnitus symptoms were recorded using a medical history questionnaire.
A significantly larger number of patients with T2DM (45.1%) were affected by hearing loss, compared to pre-diabetes patients (23.6%; p = .04) and control subjects (25.6%; p = .02), as assessed by PTA. There was no significant difference in PTA between the number of pre-diabetes patients and control subjects. In contrast, mean DPOAEs amplitudes of the pre-diabetes patients were significantly lower than of the control subjects, at all frequencies investigated, except 0.75 kHz. A significantly greater number of pre-diabetes patients reported tinnitus symptoms.
Diabetes is associated with bilateral sensorineural hearing loss, especially at high frequencies. While pre-diabetes is not necessarily associated with significant hearing loss, there may be cochlear malfunction, as indicated by DPOAEs. Thus, patients with pre-diabetes who have tinnitus may benefit from DPOAEs and PTA tests.
2型糖尿病(T2DM)与听力损失之间的关联尚未得到充分研究,关于糖尿病前期对中国受试者听觉功能改变的影响的信息也很少。
该研究招募了51例T2DM患者、55例糖尿病前期患者和43例对照受试者。通过纯音听力测试(PTA)和畸变产物耳声发射(DPOAE)评估听觉功能。使用病史问卷记录耳鸣症状。
通过PTA评估,与糖尿病前期患者(23.6%;p = 0.04)和对照受试者(25.6%;p = 0.02)相比,T2DM患者中受听力损失影响的人数显著更多(45.1%)。糖尿病前期患者和对照受试者之间的PTA没有显著差异。相比之下,除0.75kHz外,在所有研究频率下,糖尿病前期患者的平均DPOAE振幅均显著低于对照受试者。报告耳鸣症状的糖尿病前期患者数量显著更多。
糖尿病与双侧感音神经性听力损失有关,尤其是在高频。虽然糖尿病前期不一定与显著的听力损失有关,但如DPOAE所示,可能存在耳蜗功能障碍。因此,有耳鸣的糖尿病前期患者可能会从DPOAE和PTA测试中受益。